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Skin wound healing is a complex process requiring the coordinated behavior of many cell
types, especially in the proliferation and migration of fibroblasts. Basic fibroblast growth
factor (bFGF) is a member of the FGF family that promotes fibroblast migration, but the
underlying molecular mechanism remains elusive. The present RNA sequencing study
showed that the expression levels of several canonical Wnt pathway genes, including
Wnt2b, Wnt3, Wnt11, T-cell factor 7 (TCF7), and Frizzled 8 (FZD8) were modified by
bFGF stimulation in fibroblasts. Enzyme-linked immunosorbent assay (ELISA) analysis
also showed that Wnt pathway was activated under bFGF treatment. Furthermore,
treatment of fibroblasts with lithium chloride or IWR-1, an inducer and inhibitor of
the Wnt signaling pathway, respectively, promoted and inhibited cell migration. Also,
levels of cytosolic glycogen synthase kinase 3 beta phosphorylated at serine9 (pGSK3β
Ser9) and nuclear β-catenin were increased upon exposure to bFGF. Molecular and
biochemical assays indicated that phosphoinositide 3-kinase (PI3K) signaling activated
the GSK3β/β-catenin/Wnt signaling pathway via activation of c-Jun N-terminal kinase
(JNK), suggesting that PI3K and JNK act at the upstream of β-catenin. In contrast,
knock-down of β-catenin delayed fibroblast cell migration even under bFGF stimulation.
RNA sequencing analysis of β-catenin knock-down fibroblasts demonstrated that
β-catenin positively regulated the transcription of bFGF and FGF21. Moreover, FGF21
treatment activated AKT and JNK, and accelerated fibroblast migration to a similar
extent as bFGF does. In addition, ELISA analysis demonstrated that both of bFGF and
FGF21 were auto secretion factor and be regulated by Wnt pathway stimulators. Taken
together, our analyses define a feedback regulatory loop between bFGF (FGF21) and
Wnt signaling acting through β-catenin in skin fibroblasts.
Keywords: cell migration, bFGF, transcriptome, Wnt signaling pathway, β-catenin, GSK3β
Abbreviations: bFGF, basic fibroblast growth factor; ChIP, chromatin immunoprecipitation; DMSO, dimethyl sulfoxide;
ECM, extracellular matrix; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; FGFR, fibroblast growth
factor receptor; FZD8, Frizzled 8; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GO, gene ontology; GSK-3β,
glycogen synthase kinase 3β; JNK, c-Jun N-terminal kinase; LiCl, lithium chloride; PBS, phosphate buffered saline; PI3K,
phosphatidylinositol 3-kinase; qRT-PCR, quantitative real-time polymerase chain reaction; RNA-Seq, RNA-sequencing;
siRNA, small interfering RNA; TCF7, T-cell factor 7.
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INTRODUCTION
Skin serves as a barrier to protect internal tissues from the
external environment, playing a crucial role in life sustenance
(Enoch and Price, 2004). Skin wounding can be caused by tears,
cuts, or contusions (Pazyar et al., 2014), and presents as a split
in the epidermis, as well as deeper punctures extending to the
dermis, subcutaneous fat, fascia, muscles, or the bone itself
(Enoch and Price, 2004). The net result is morbidity from loss
of function, negative psychosocial effects from disfigurement, or
even mortality from loss of the skin’s barrier function (Amini-Nik
et al., 2014). Therefore, it is essential that any wound sustained by
the skin is fully healed to restore homeostasis.
Wound healing is a complex biological process (Thamm et al.,
2013) that requires the actions of various cell types, including
keratinocytes, fibroblasts, endothelial cells, macrophages,
and platelets. These cells undergo proliferation, migration,
infiltration, and inflammatory events, in addition to stimulation
by and activation of growth factors and ECM signaling molecules
to rebuild the skin (Martin, 1997; Wagner and Wehrmann,
2007). Cell migration and proliferation are important processes
that both require and trigger new ECM synthesis, thereby
contributing to wound healing (Epstein et al., 1999). Fibroblast
proliferation and migration are especially critical to the
formation of granulation tissue and wound healing (Kanazawa
et al., 2010).
Wound healing processes are regulated by numerous growth
factors, including FGFs (Xuan et al., 2014). As one of the
FGFs, bFGF/FGF2 is involved in many biological activities (e.g.,
cell growth, cell and tissue differentiation, and cell migration)
(Dvorak and Hampl, 2005). Our previous studies reported that
bFGF promoted wound closure through the PI3K/Rac1/JNK
pathway and NFκB-JNK pathway (Xuan et al., 2014, 2016).
The canonical Wnt signaling pathway, also known as the
β-catenin pathway or the β-catenin/ TCF pathway (Shtutman
et al., 1999), likewise regulates a wide array of biological
processes (Moon et al., 2004; Clevers, 2006; Brack et al.,
2007). The hallmark of the Wnt/β-catenin pathway is the
stabilization of cytosolic β-catenin. Under unstimulated
conditions, β-catenin is constantly phosphorylated by a
destruction complex consisting of GSK3β and other proteins
(Gordon and Nusse, 2006); phosphorylated β-catenin is
ubiquitinated by this complex and targeted for degradation
by the proteasome (Aberle et al., 1997; Gordon and Nusse,
2006). Activation of the Wnt cascade inhibits GSK3β
activity, allowing β-catenin to accumulate and enter the
nucleus, where it associates with TCF/LEF, leading to the
transcription of Wnt signaling genes that participate in cell
survival, proliferation, and differentiation (Gordon and Nusse,
2006).
Previous study reported that FGF and Wnt/β-catenin
signaling involved in collective cell migration (Aman and
Piotrowski, 2008), additionally, Bergmann et al. (2011) also define
the activation of Wnt pathway in fibroblast facilitate the release
of collagen. Moreover, stimulation of osteoblast differentiation
and bone formation is partially mediated by bFGF modulation of
the Wnt pathway (Fei et al., 2011). However, the molecular basis
for the relationship between bFGF and Wnt signaling during
fibroblast migration is remained to be established.
Here, we performed an RNA sequencing analysis to gain
insights into the molecular mechanism of bFGF-mediated
wound healing, and identified 830 differentially expressed
genes in bFGF-treated versus untreated fibroblasts. GO and
pathway analyses distinguished a number of significantly altered
molecular pathways, especially in the canonical Wnt signaling
pathway. Moreover, GSK3β activity was decreased in response to
bFGF treatment, while knock-down of β-catenin resulted in delay
of cell migration. Lastly, suppression of β-catenin in fibroblasts
led to repression of bFGF and FGF21, which detected with the
identical effect on the activation of AKT and JNK, and the
acceleration of cell migration.
To date, several studies have drawn attention to the role of
FGF21 in modulation glucose homeostasis by binding to FGF
receptor 1c isoform in the present of the cofactor β-klotho. Here,
we report for the first time the involvement of FGF21 in fibroblast
migration.
Taken together, our findings provide a new mechanism
whereby bFGF (FGF21) and Wnt signaling are tightly connected
to maintain fibroblast cell migration through β-catenin.
MATERIALS AND METHODS
Ethics Statement
Human foreskin samples were collected from volunteers at
the First Affiliated Hospital, Wenzhou Medical University. All
volunteers were informed of the purpose and procedures of this
study and agreed to offer their tissue specimens with written
consent. All protocols for human studies were approved by the
Ethics Committee of the First Affiliated Hospital of Wenzhou
Medical University.
Cell Culture
The NIH/3T3 mouse embryo fibroblast cell lines were purchased
from American Type Cell Collection (ATCC, Manassas, VA,
USA) and cultured in DMEM, which contained 5.5 mM glucose,
10% FBS and 1% penicillin-streptomycin. Cells passaged 3–15
times were selected for the following experiments.
While for primary human foreskin fibroblasts, fat was
removed from all tissue samples, which were cut into 3 mm
strips and incubated with 0.05% dispase neutral protease (Sigma-
Aldrich, St. Louis, MO, USA). The tissues in digestion buffer were
incubated with Dulbecco’s Modified Eagle’s Medium (DMEM;
Gibco BRL, Grand Island, NY, USA) supplemented with 10%
FBS (Gibco BRL) and 1% penicillin-streptomycin (Gibco BRL)
at 4◦C overnight. The epidermis was removed from the dermis,
and the dermis was finely minced and placed into FBS-coated
25 cm2 flasks. The flasks were placed horizontally for 1 h and
then vertically for 3 h in an atmosphere of 5% CO2 at 37◦C.
The tissues were then cultured in DMEM supplemented with
5.5 mM glucose, 10% FBS, and 1% penicillin-streptomycin,
with subsequent changes of the medium every 3 days. Cultured
cells were passaged using 0.25% trypsin (Gibco BRL) after cell
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confluence reached ∼80%. The human fibroblasts were used for
various studies described below after 3–6 passages.
Total RNA Extraction, cDNA Synthesis,
and Quantitative Real-Time Polymerase
Chain Reaction (qRT-PCR)
Total RNA was extracted from primary human fibroblasts cells
with or without 1 h bFGF treatment (100 ng/mL) (Xuan et al.,
2016). Our results showed that bFGF represses the protein levels
of β-catenin in fibroblasts after 30 min of bFGF treatment
(Supplementary Figure S1C). Therefore, total RNA was extracted
from the mouse NIH3T3 fibroblast cell line with or without
30 min bFGF treatment (100 ng/mL), and β-catenin knock-down
NIH3T3 cells for the RNA-Seq experiments. Cell monolayers
were rinsed once with ice-cold phosphate-buffered saline, lysed
directly in 3.5 cm culture dishes by adding 1 mL of Trizol Reagent
(Invitrogen, Carlsbad, CA, USA) to each dish, and scraped with
a cell scraper. Chloroform (0.2 mL) was added to 1 mL of cell
lysate, and total RNA was extracted. Total RNA (2 µg) was
reverse-transcribed using a GoScript Reverse Transcription Kit
(Promega, Madison, WI, USA) according to the manufacturer’s
instructions. Next, qRT-PCR was performed to quantify the
expression of selected genes, as previously described (Zittermann
and Issekutz, 2006). The mRNA levels were normalized against
that of GAPDH. Gene-specific primer sequences used for qRT-
PCR are listed in Supplementary Table S1.
RNA Sequencing
Total RNA extracted from untreated or bFGF-treated
(100 ng/mL, 1 h) human foreskin fibroblasts and β-catenin
knock-down NIH3T3 cells were used for the RNA sequencing
experiments. RNA sequencing was performed using a kit
provided by LC Biotech, Co., Ltd (http://www.lc-bio.com/;
Hangzhou, China), and data analyses were performed by Novel
Bioinformatics, Co., Ltd (http://www.novelbio.com/; Shanghai,
China).
Analysis of GO Categories, Signaling
Pathways, and Co-expression Networks
Differentially expressed genes were determined from statistical
outcomes by testing for association with biological process GO
terms (Consortium, 2006). Fisher’s exact test was used to classify
the GO categories, and the false discovery rate (FDR) was
calculated to correct the P-value, where the smaller the FDR, the
smaller the error in judging the P-value (Dupuy et al., 2007).
Enrichment of GO members among differentially expressed
probe sets was identified using the one-tailed Fisher’s exact test
according to 2 × 2 contingency tables (Dunnick et al., 2012).
This provides a measure of the significance of the function. As
the enrichment increases, the corresponding function is more
specific, which helps in distinguishing GOs with a more concrete
function.
Pathway analysis was used to determine the significance
of assorted gene sets according to the Kyoto Encyclopedia of
Genes and Genomes (KEGG), Biocarta, and Reactome databases.
Fisher’s exact test was followed by Benjamini-Hochberg (BH)
multiple testing correction to select the most significant
pathway(s), and the threshold of significance was defined by the
P-value and the FDR (Draghici et al., 2007).
Wound Healing Assay
Cell migration was determined using a standard wound healing
scratch assay. Cells were seeded into six-well plates and cultured
overnight. Confluent cells were cultured in DMEM supplemented
with 0.5% FBS for 24 h, and then wounded by creating a 1 mm
linear scratch with a sterile pipette tip. Images of the wounded
cell monolayers were taken under a Model IX70 Microscope
(Olympus, Tokyo, Japan) at 0, 12, and 24 h after wounding.
Cell migration into the wounded area was recorded for 24 h
using the same microscope equipped with a CoolSNAP HQ
CCD Camera (Nippon Roper, Chiba, Japan) and MetaMorph
Software (Universal Imaging, Co., Ltd, Buckinghamshire, UK).
All experiments were performed in the presence of 5 mg/mL
mitomycin-C to inhibit cell proliferation. Concentrations of
LiCl (Sigma) and IM-12 (Selleck), inhibitor of GSK3β and
promotor of Wnt signaling, and IWR-1 (Sigma) and XAV-939
(Selleck), inhibitors of Wnt signaling, were tested and shown in
Supplementary Figure S1. Concentrations of FGF21 and BGJ 398,
an inhibitor of FGFR, were tested and shown in Supplementary
Figure S7.
To observe the relationship between Wnt signaling and bFGF
activation in cell migration, cells were pretreated with 1.0 µM
IWR-1, 1.0 µM bFGF, or 1.0 µM IWR-1 plus 1.0 µM bFGF for
1 h before wounding. 24 h after wounding, the distance from 20
selected cells and the wound leading edge just after wounding was
measured using Image J software (National Institutes of Health).
Western Blot Analysis
Cells were harvested in an ice-cold lysis solution (7 M
urea, 2 M thiourea, 2% CHAPS, 40 mM Tris base, 40 mM
dithiothreitol, and 1% protease inhibitor) to procure whole
cell extracts. KeyGen Nuclear-Cytosol Protein Extraction and
KeyGen Mitochondria-Cytosol Protein Extraction Kits (Nanjing
KeyGen Biotech., Co., Ltd, Nanjing, China) were used for
protein isolation from the nucleus and the cytosol, respectively
(Zhang et al., 2010). Protein concentrations were measured
using the bicinchoninic acid protein assay reagent (Pierce/Life
Technologies, Grand Island, NY, USA). Equal amounts of protein
were loaded into each lane of a sodium dodecyl sulfate (SDS)-
polyacrylamide gel, electrophoretically separated, and transferred
onto a polyvinylidene difluoride (PVDF) membrane (Bio-Rad,
Hercules, CA, USA). Membranes were blocked with 5% bovine
serum albumin in Tris-buffered saline/Tween 20 (TBST) for
1 h and then incubated with the following primary antibodies
overnight at 4◦C: anti-GAPDH (Abcam, Cambridge, MA,
USA), anti-β-actin (Cell Signaling Technology, Beverly, MA,
USA), anti-β-catenin (Abcam), anti-phospho-GSK3β (pGSK3β
Ser9) (Cell Signaling Technology), anti-GSK3β (Cell Signaling
Technology), anti-pAKT Ser473 (Cell Signaling Technology),
anti-total-AKT (Cell Signaling Technology), and anti-phospho-
stress activated protein kinase (pSAPK)/JNK Thr183/Tyr185 (Cell
Signaling Technology). After washing three times with TBST,
blots were incubated with appropriate secondary antibodies
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(Cell Signaling Technology) at room temperature for 90 min.
Finally, after washing with TBST, the antigen-antibody complexes
on the PVDF membranes were visualized using an enhanced
chemiluminescence kit (GE Healthcare, Piscataway, NJ, USA).
Protein levels were normalized against GAPDH using Image J
software, as previously described (Fei et al., 2011).
Small Interfering RNA (siRNA)
Experiments
The siRNA targeting the mouse PI3-kinase p110α (Cat. no.
sc-39128) was purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA). NIH3T3 cells were seeded 12 h before
transfection, with a cell density of 30–50% confluence at the
time of transfection. Next, the siRNA (40 nM) was transfected
into the cells using Lipofectamine 2000 (Invitrogen) and Opti-
MEMI reduced serum medium (Gibco BRL). After 24 h of
transfection, cells were processed by semi-quantitative RT-PCR
for the detection of PI3K p110α mRNA levels and Western
blotting for the detection of p-GSK3β Ser9 levels.
Silencing of Endogenous β-Catenin in
Fibroblast Cells
The siRNA sequence used for the knock-down of β-catenin was
as follows: 5′-GAACGCAGCAGCAGTTTGT-3′, as described by
Singh et al. (2009), (nucleotides 124–142 on NM-007614.3).
For lentiviral infection of NIH3T3 cells, cells were seeded at
a density of 2 × 105 cells per well in 24-well plates. After
overnight culture, various amounts of lentivirus (3, 10, or 12 µL)
(OBIO Technology, Co., Ltd, Shanghai, China) were added
to the wells in the presence of 4 mg/mL Polybrene (Sigma-
Aldrich, St. Louis, MO, USA). The plates were then centrifuged
at 2,500 rpm at room temperature for 1 h and returned to the
culture incubator. 24 h after infection, the resulting NIH3T3 cell
cultures were analyzed for green fluorescence protein expression
(GFP; a reporter) by confocal microscopy. Cells treated with
12 µL lentivirus were chosen for the knock-down experiments
described below.
Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assay was performed to detect
the levels of FGFs (bFGF and FGF21, Multi Sciences, China)
and Wnt3a (Enzyme-linked Biotechnology, Co., Ltd, Shanghai,
China) according to the manufacturer’s instructions. Fibroblasts
were seeded in 6-well plates and cultured for 24 h. To
determine the assay of FGFs secreted by fibroblast, cell culture
supernatants were collected after 24, 36, and 48 h, respectively.
To determine the effect of β-catenin on FGFs secretion, after
24 h incubation, the media were replaced with fresh media
containing 1.0 µM LiCl, 1.0 µM IWR-1, 0.5 µM IM-12 or
0.5 µM XAV-939, and the cells were then cultured for 48 h. To
investigate Wnt3a secretion under FGFs treatment, fibroblasts
were cultured in the fresh media containing 100 ng/mL bFGF
or FGF21. Then, cell culture supernatants were collected
to determine FGFs (bFGF and FGF21) and Wnt3a protein
levels.
ChIP Assay
Chromatin immunoprecipitation assay was performed by using
a ChIP assay kit (cat no. 17-295, Millipore, Billerica, MA,
USA) according to the manufacturer’s instructions. Cells
were cross-linked with 1% formalin. DNA is extracted from
immunoprecipitates of β-catenin Ab (Abcam, ab32572). For
PCR, 2 uL from 30 uL of DNA extraction was used. The primer
sequences for qRT-PCR are listed in Supplementary Table S1.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 5
Software (GraphPad, San Diego, CA, USA). All data were
expressed as mean ± the standard error (SE). Comparisons
between two groups were performed using Student’s t-test.
RESULTS
Identification of a bFGF-Regulated
Transcriptome in Fibroblasts
To determine the effects of Wnt pathway gene expression after
bFGF treatment, gene expression levels were analyzed using
primary human fibroblast cells with or without bFGF treatment
for 1 h (Xuan et al., 2016). RNA sequencing results revealed
that 830 genes were differentially expressed in bFGF-treated
fibroblasts. Among them, 473 genes were down-regulated, while
357 genes were up-regulated (P < 0.05 and fold change > 1.5)
(Figure 1A) (Fei et al., 2011).
The significance of these altered gene expression levels
was further assessed from statistical outcomes by testing for
association with biological process GO terms. Pathway analysis
was used to assess the significance of the differentially expressed
gene sets according to KEGG, which demonstrated the following
gene clusters that were significantly altered in bFGF-treated
fibroblasts: seven up-regulated clusters (cytokine-cytokine
receptor interactions, ECM-receptor interactions, transcriptional
misregulation in cancer, human T-cell lymphotropic virus
type 1 (HTLV-1) infection, Salmonella infection, hepatitis
B, and hematopoietic cell lineage) and nine down-regulated
clusters (Wnt signaling pathway, nuclear factor-kappa B
signaling pathway, tumor necrosis factor signaling pathway,
ECM-receptor interactions, Hippo signaling pathway, HTLV-1
infection, NOD-like receptor signaling pathway, Hedgehog
signaling pathway, and insulin signaling pathway). As shown
in Figure 1B, Wnt2B, Wnt11, and Wnt3 were down-regulated,
whereas Frizzled 8 (FZD8) and T-cell factor 7 (TCF7) were up-
regulated in bFGF-treated fibroblasts. Furthermore, the changes
in Wnt pathway genes (FZD8, Wnt2B, Wnt11, Wnt3, and TCF7)
were verified by qRT-PCR, and the data were consistent with the
RNA sequencing results (Figure 1C). These findings indicate
that bFGF regulates Wnt signaling genes in fibroblasts.
The Wnt/β-Catenin Pathway Positively
Regulates Fibroblast Migration
Since the expression levels of key Wnt signaling genes were
significantly changed after bFGF treatment in skin fibroblasts,
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FIGURE 1 | Basic fibroblast growth factor-regulated Wnt signaling genes in skin fibroblasts. (A) Heat map representation of genes whose expression levels
were altered after 1 h of bFGF (100 ng/mL) treatment in human fibroblasts. Gene expression is shown by a pseudocolor scale, with yellow denoting low levels of
gene expression, and red denoting high levels of gene expression (P < 0.05). (B) bFGF-regulated Wnt-related genes were classified into up-regulated and
down-regulated clusters. (C) qRT-PCR was performed to monitor the mRNA levels of FZD8, Wnt2b, Wnt11, Wnt3, and TCF7. GAPDH was used as an internal
control. Data represent mean values ± the SE (n = 5 replicates; ∗P < 0.05, ∗∗P < 0.01 versus the untreated control group; Student’s t-test).
the role of Wnt signaling during human fibroblast migration
was further analyzed. LiCl is an inhibitor of GSK3β (Klein and
Melton, 1996) that activates the Wnt pathway, and accelerated
cell migration herein throughout the course of the 24 h wound
healing assay (Figures 2A,B; Supplementary Figure S1). By
contrast, the Wnt pathway inhibitor, IWR-1 (Clevers and Nusse,
2012), delayed cell migration. Interestingly, bFGF accelerated
migration of the fibroblasts, and slightly overturned the reduced
cell migration caused by IWR-1 (Figures 2A,B). In addition,
this critical effect of Wnt pathway on wound healing was
further confirmed by IM-12 and XAV-939, another common
used agonist and antagonist of Wnt signaling, respectively
(Supplementary Figure S1) (Jeong et al., 2014; Cai et al., 2016).
Effect of bFGF on Nuclear β-Catenin
Accumulation and GSK3β
Phosphorylation
The results from the cell migration assay indicated that Wnt
signaling is important for skin wound healing. β-catenin is
known as an essential transcription factor in the Wnt pathway
that translocates from the cytosol to the nucleus to activate
downstream target genes (Salic et al., 2000). Western blot
analysis showed that bFGF or LiCl treatment increased nuclear
β-catenin level, whereas IWR-1 reduced nuclear β-catenin level
(Figures 2C,E).
To further analyze the potential mechanism by which
bFGF regulates β-catenin degradation by proteasome,
GSK3β phosphorylation levels were analyzed, because
GSK3β phosphorylates β-catenin which further results in
its degradation. On the other hand, GSK3β phosphorylation is
reportedly involved in cell migration in various cellular systems
(Etienne-Manneville and Hall, 2003; Bianchi et al., 2005; Sun
et al., 2009; Harris and Nelson, 2010). Phosphorylation at Ser-9
inactivates GSK3β, which results in β-catenin stabilization and
nuclear accumulation and leads to enhanced Wnt signaling (Fei
et al., 2011). Therefore, we tested the effect of bFGF on GSK3β
phosphorylation level. Figures 2D,F showed that bFGF and LiCl
treatment increased the phosphorylation of GSK3β at Ser9 in
fibroblasts, but no significant differences were observed between
IWR-1-treated and control groups (Boku et al., 2013). These
results suggested that bFGF inhibits GSK3β activity through
increased phosphorylation of Ser9.
bFGF/PI3K/JNK Signaling Activates the
Wnt/β-Catenin Signaling Pathway
The PI3K/Rac1/JNK pathway functions at the downstream
of bFGF during fibroblast migration (Kanazawa et al., 2010).
Moreover, PI3K induces phosphorylation of AKT at Ser473,
thereby facilitating the phosphorylation of GSK3β at Ser9,
which in turn inactivates GSK3β kinase activity (Cohen and
Frame, 2001; Engelman et al., 2006). To verify the relationship
between PI3K-AKT and GSK3β in fibroblast, biochemical
and pharmacological tests were further performed. Application
of the PI3K inhibitor, LY294002 (cell signaling technology),
substantially suppressed AKT and GSK3β phosphorylation levels
in fibroblasts (Figures 3A–C). Contrarily, LiCl treatment did
not change pAKT levels (Figure 3D), while pGSK3β Ser9 levels
were increased (Figure 3E). In view of the fact that bFGF
induced the neuroblast migration is mediated by modulating
FGFR1 signaling via the PI3K P110 alpha isoform, specifically
through the phosphorylation of PI3K downstream effectors, AKT
and GSK3β (Hu et al., 2013), PI3K P110 alpha siRNA was
transformed into NIH3T3 cells and PI3K levels were monitored.
The data showed that both siRNA-mediated suppression of PI3K
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FIGURE 2 | Effects of LiCl, bFGF, and IWR-1 treatment on cell migration, nuclear β-catenin, and GSK3β phosphorylation levels in skin fibroblasts.
(A) A wound healing assay was performed after treatment with LiCl (1.0 µM), bFGF (100 ng/mL), IWR-1 (1.0 µM), or bFGF (100 ng/mL) plus IWR-1 (1.0 µM). The
wounded cell monolayers were photographed at 0, 12, and 24 h after treatment. White vertical lines indicate the borders of the wound area. Bar = 500 µm. (B) Cell
migration distances shown in (A) were measured and plotted (∗P < 0.05, ∗∗P < 0.01; Student’s t-test). (C) Nuclear β-catenin levels were altered upon treatment with
bFGF, LiCl, or IWR-1. Preparation of nuclear lysates and Western blots were performed at 30 min (bFGF) or 1 h after each treatment. Nuclear lysates (20 µg of total
protein) were loaded into each lane of the gel, electrophoresed, and transferred to a PVDF membrane. (D) Phosphorylation levels of GSK3β at Ser9 were altered by
treatment with bFGF, LiCl, and IWR-1. The cells were stimulated with bFGF (100 ng/mL), LiCl (1 µM), or IWR-1 (1 µM) for 30 min or 1 h, and cell lysates (20 µg) were
loaded into each lane of a SDS-polyacrylamide gel, electrophoresed, and transferred to a PVDF membrane. Densitometry data for β-catenin (C) or pGSK3β Ser9 (D)
from the blot shown in (E,F) were normalized to those of Lamin B or GSK3β. The results are presented as fold changes relative to control fibroblasts grown in
5.5 mM glucose-containing DMEM. Data represent mean values ± the SE (n = 5 independent experiments; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; Student’s t-test).
Con, control.
(P110 alpha) (Fukui et al., 2010) and neutralization of bFGF in
the culture medium by a bFGF antibody reduced GSK3β Ser9
phosphorylation levels (Supplementary Figure S2).
JNK is a downstream regulator of PI3K that is reportedly
involved in bFGF-regulated fibroblast migration (Kanazawa
et al., 2010). In next, role of JNK in regulation of GSK3β
phosphorylation was tested. The results showed that significant
decrease of β-catenin and pGSK3β Ser9 were found in
human fibroblasts treated with SP600125, a JNK inhibitor
(Figures 3F–I). However, JNK phosphorylation levels did not
differ with LiCl treatment (Figure 3J). Taken together, these
results confirmed that bFGF/PI3K/JNK signaling acts at the
upstream of GSK3β.
β-Catenin Is Critical for bFGF-Mediated
Cell Migration
To determine the role of β-catenin in fibroblast migration, β-
catenin-specific siRNA was used to repress β-catenin expression
(Singh et al., 2009). Because human foreskin fibroblasts are
Frontiers in Pharmacology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 32
fphar-08-00032 February 1, 2017 Time: 17:23 # 7
Wang et al. Feedback between bFGF and Wnt
FIGURE 3 | Basic fibroblast growth factor activates the GSK3β/β-catenin/WNT signaling pathway via the PI3K/JNK pathway. Human skin fibroblasts
were treated for 1 h with the specific PI3K inhibitor, Ly294002 (1.0 µM), the GSK3β inhibitor, LiCl (1.0 µM), or solvent control. (A) Total cell lysates were then
prepared and analyzed via Western blotting. Akt Ser473 and GSK3β Ser9 phosphorylation levels were blocked by Ly294002. (D) GSK3β Ser9 phosphorylation was
increased by treatment with LiCl. (F) Nuclear β-catenin levels were increased by treatment with the JNK inhibitor, SP600125. (G) Phosphorylation levels of GSK3β at
Ser9 were reduced by treatment with SP600125 for 1 h. (J) JNK phosphorylation was unchanged by LiCl treatment. Densitometry was performed on 3–4 Western
blots (each representative of an independent experiment) per condition. Densitometry data for pAKT (B) or pGSK3β Ser9 (C) from the blots shown in (A) were
normalized to those of AKT or GSK3β. Densitometry data for pGSK3β Ser9 (E) from the blot shown in (D) were normalized to those of GSK3β. Densitometry data for
nuclear β-catenin (H) from the blot shown in (F) were normalized to those of Lamin B. Densitometry data for pGSK3β Ser9 (I) from the blot shown in (F) were
normalized to those of GSK3β. The results are presented as fold changes relative to control fibroblasts grown in 5.5 mM glucose-containing DMEM. Data represent
mean values ± the SE (n = 5 independent experiments; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; Student’s t-test). Con, control.
active for a maximum of six generations or passages, they are
not suitable for lentivirus-mediated transfection experiments.
Thus, mouse NIH3T3 cells were employed for the siRNA
experiments. The results showed that endogenous β-catenin
levels in NIH3T3 cells were reduced by ∼50–95% following
transfection (Supplementary Figure S3). Furthermore, β-catenin
knock-down NIH3T3 cells exhibited a reduced rate of cell
migration compared with control cells (Figure 4A), and LiCl or
IWR-1 treatment exerted no effect on the β-catenin knock-down
cell line (Supplementary Figure S4). Also, bFGF administration
only slightly increased the migration rate of β-catenin knock-
down cells (Figure 4B), indicating that β-catenin is necessary to
promote bFGF-mediated fibroblast migration.
β-Catenin Activates FGFs
RNA sequencing analysis was performed to examine
transcriptome changes in β-catenin knock-down NIH3T3
cells. We found that 411 genes were differentially expressed in
the β-catenin knock-down group. Among them, 201 genes were
up-regulated, and 210 genes were down-regulated (P < 0.05 and
fold change > 2.0) (Supplementary Table S2). These findings
were further validated from statistical outcomes in tests for
association with biological process GO terms (Supplementary
Figure S5). Pathway analysis was used to determine the
significance of the differentially expressed gene sets according
to KEGG, which demonstrated that six up-regulated and six
down-regulated clusters were significantly enriched by silencing
of β-catenin (Figure 5). Interestingly, FGF21 as well as bFGF
expression levels were sensitive to β-catenin. According to the
expression patterns summarized in Figure 6A, bFGF and FGF21
were reduced significantly as well as Wnt pathway-related gene
FZD8, and Wnt3a was increased by β-catenin-specific siRNA.
FGF21, a secreted protein (Badman et al., 2007), which is
the most studied family member, and has been reported to
be preferentially expressed in the liver early in development
(Nishimura et al., 2000). However, recent studies have reported
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FIGURE 4 | Effect of siRNA-mediated inhibition of β-catenin in NIH3T3 cell migration. (A) A wound healing assay was performed in cells transfected with
scrambled control siRNA or β-catenin siRNA with or without bFGF (100 ng/mL). The wounded cell monolayers were photographed at 0 and 12 h after the treatment.
White vertical lines indicate the borders of the wound area. Bar = 500 µm. (B) Cell migration distances shown in (A) were measured and plotted (∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001; Student’s t-test). Con, control.
FIGURE 5 | Pathway analysis of β-catenin-regulating genes. β-catenin suppression-regulating genes were classified into an up-regulated cluster and a
down-regulated cluster.
that FGF21 production is inducible by starvation or drug
administration, and revealed its diverse functions in glucose
homeostasis and protection of the liver and heart from injury (Lin
et al., 2013, 2014; Liang et al., 2014).
To further understand the influence of FGF21 in cell
migration, wound healing scratch assay and Western blot were
performed on NIH3T3 cells with FGF21 treatment. The results
showed that FGF21 promoted cell migration of fibroblasts
and β-catenin-suppressed NIH3T3 cells (Figures 6B,C;
Supplementary Figures S6A–C). In addition, Western blot
analysis showed that exogenous FGF21 treatment increased AKT
phosphorylation levels (Figures 6D,E), and neutralization of
FGF21 in the culture medium by a FGF21 antibody reduced
GSK3β Ser9 phosphorylation levels to the same extent as bFGF
(Supplementary Figures S6D,E). Taken together, these results
suggest that FGF21 acted similarly to bFGF, therefore, it is
necessary to further examine its roles in fibroblast cell migration.
A Feedback Activation of bFGF via the
Wnt/β-Catenin Pathway
Wnt3a, known as a main sign of activation of Canonical Wnt
pathway, was assayed by ELISA (Shimizu et al., 1997). As
shown in Figure 7A, Wnt3a in fibroblasts is increased upon
Frontiers in Pharmacology | www.frontiersin.org 8 February 2017 | Volume 8 | Article 32
fphar-08-00032 February 1, 2017 Time: 17:23 # 9
Wang et al. Feedback between bFGF and Wnt
FIGURE 6 | Role of FGF and β-catenin in fibroblast migration and downstream regulations. (A) qRT-PCR was performed to monitor the mRNA levels of
FGF2, FGF21, FZD8, and Wnt3a. GAPDH was used as an internal control. Data represent mean values ± the SE of five replicates (∗∗P < 0.01, ∗∗∗P < 0.0001
versus the untreated control group; Student’s t-test). (B) A wound healing assay was performed with or without FGF21 treatment (200 ng/mL), and the wounded cell
monolayers were photographed 0 and 12 h later. White vertical lines indicate the borders of the wound area. Bar = 500 µm. (C) Cell migration distances were
measured based on the data shown in (B). Data represent mean values ± the SE of five replicates (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.0001; Student’s t-test).
(D) Western blotting was performed to analyze the protein levels of pAKT after 30 min treatment of fibroblasts with bFGF (100 ng/mL) or FGF21 (200 ng/mL).
Densitometry data for pAKT (E) from the blot shown in (D) were normalized to those of AKT. All experiments were performed 24 h after application of 5 µg/mL
mitomycin-C (a cell proliferation inhibitor). Data represent mean values ± the SE (n = 5 independent experiments; ∗∗∗P < 0.0001 versus untreated control; Student’s
t-test). Con, control.
FIGURE 7 | Effect of bFGF on the secretion of Wnt3a and the Effects of normal condition and Wnt pathway agonists and antagonists on the secretion
of bFGF and FGF21 in fibroblasts by ELISA. (A) The cultured cells were treated with 100 ng/mL bFGF for 24 h, and the cell supernatants were collected to
detect Wnt3a-secreted level. The results are presented the secretion of Wnt3a in fibroblasts is increased upon bFGF stimulation for 24 h. (B,C) The cells were
cultured normally, and the cultured supernatants were collected after 24, 36, 48 h, respectively. The results are presented the release of bFGF and FGF21 in
fibroblasts grown in 5.5 mM glucose-containing DMEM for 24 h. (D,E) The cultured cells were treated with 1.0 µM LiCl, 0.5 µM IM-12, 1.0 IWR-1, 0.5 µM XAV-939
or vehicle for 24 h, and the cell supernatants were collected to test the bFGF and FGF21 release. Elisa analysis showed that the secretion of bFGF and FGF21 in
fibroblasts is up regulated upon LiCl and IM-12 stimulation for 24 h, while down regulated upon IWR-1 and XAV-939. Data represent mean values ± the SE (n = 5
independent experiments; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; Student’s t-test). Con, control.
bFGF stimulation, which further confirmed that Wnt signaling
output was increased by bFGF treatment. On the other hand,
the secretion of bFGF and FGF21 were analyzed under normal
condition, Wnt pathway agonist and antagonist treatment,
respectively (Figures 7B–E). The results showed that the LiCl
and IM-12 treatment increased secretion of bFGF and FGF21,
but decreased by IWR-1 and XAV-939 treatment. Besides, cell
migration was reduced by addition of neutralizing antibody
of bFGF and FGF21 in the culture medium (Supplementary
Figure S7A). Moreover, BGJ398, an inhibitor of FGFR (Costa
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FIGURE 8 | Schematic representation of the crosstalk between the
Wnt and FGF signaling pathways in fibroblasts. For additional
explanation, please see text.
et al., 2014), slowed migration dramatically, which suggested that
a feedback regulatory loop between bFGF (FGF21) and Wnt
signaling acting through β-catenin in skin fibroblasts.
β-Catenin Directly Activates FGF21
Transcription but not of bFGF
Basic fibroblast growth factor and FGF21 promoter sequences
analysis showed that two and three putative TCF/LEF binding
motifs (AGAAAG) (Schuijers et al., 2014), respectively, were
appeared within 3 kb of bFGF and FGF21 promoters. Also,
β-catenin interacts with TCF/LEF, and activates the transcription
of Wnt signaling genes after β-catenin accumulated in the
nucleus (Gordon and Nusse, 2006). Therefore, the possibility of
β-catenin complex binding to the bFGF and FGF21 promoters
were examined. The two putative binding motifs are located 374
and 518 bp downstream of the start codon of bFGF, respectively,
while three putative binding motifs are located 976, 1062 and
2269 bp downstream of the start codon of FGF21, respectively
(Supplementary Figure S8A). To examine whether β-catenin
complex directly binds to the putative motifs, ChIP assays were
performed using β-catenin antibody. The immunoprecipitated
DNA fragments were amplified by five primer pairs which
could span P1-P5 regions located within bFGF and FGF21
promoters (Supplementary Figure S8A). The ChIP-PCR data was
normalized to input DNA and the results showed that β-catenin
complex bound to the P4 and P5 regions in the promoters of
FGF21 gene but not of P1-P3 regions in the promoters of bFGF
gene (Supplementary Figure S8B).
DISCUSSION
Migration of dermal fibroblasts is crucial for skin wound repair.
bFGF is a member of the FGF family of growth factors, and is an
efficacious promoter of fibroblast migration. Recent work showed
that bFGF activates the PI3K/Rac1/JNK pathway and NFκB-JNK
pathway to accelerate cell migration (Xuan et al., 2014, 2016).
However, up until now, little information has been available
regarding bFGF-meditated control of signaling pathways. Here,
we utilized RNA sequencing analysis to demonstrate that
Wnt/β-catenin signaling genes are regulated by bFGF. Further
analyses indicated that PI3K and JNK function upstream of
GSK3β and β-catenin, two principal regulators of Wnt signaling.
As the phosphorylation of GSK3β might be indirectly stimulated
by MAP kinase, including JNK, we investigated the possibility
of a JNK mediated increase in the GSK3β phosphorylation
level in bFGF treated fibroblasts (Stambolic and Woodgett,
1994). Coincidentally, exogenous bFGF-mediated stimulation of
fibroblasts apparently activated the PI3K/JNK pathway, which in
turn phosphorylated GSK3β and positively regulates β-catenin
shuttling between the cytoplasm and the nucleus (Figure 8).
The translocation of β-catenin from the cytoplasm into the
nucleus can then activate the downstream transcriptional factors,
TCF/LEF, promoting the transcription of Wnt target genes such
as FZD8 and Wnt3a, and also inducing the expression of bFGF
and FGF21.
Basic fibroblast growth factor, LiCl, and IM-12 significantly
accelerated cell migration. On the other hand, the Wnt
inhibitors, IWR-1 and XAV-939, delayed cell migration, and
bFGF somewhat attenuated the effects from IWR-1, which is
consistent with previous reports (Lam et al., 2011). For LiCl,
millimolar concentrations were applied in many research, which
play significant roles to study cell proliferation, differentiation,
migration (Teng et al., 2010; Azimian-Zavareh et al., 2012).
In contrast to the above reports, micromolar concentrations
of LiCl were used in some studies, which indicated that low
concentrations of LiCl could be effective therapeutic doses in
certain conditions (Nakamura et al., 2003; Zarse et al., 2011;
Huang et al., 2015; Erguven et al., 2016; Xu et al., 2016). For
instance, Erguven et al found that low concentrations of LiCl
significantly increased cell number, while high concentrations of
LiCl significantly decreased cell number. In our research, LiCl
was tested at a concentration ranging from 0.5 to 10 µM in the
cell migration. Base on the results, 1 µM LiCl was the more
appropriate concentration to enhance migration by inhibited
phosphorylation of GSK3β at Ser9, which results in β-catenin
stabilization and leads to enhanced Wnt signaling (Fei et al.,
2011). Therefore, 1 µM LiCl was applied for further experiments.
At the protein level, bFGF activates the PI3K/JNK pathway,
leading to phosphorylation of GSK3β at Ser9. Normally,
GSK3β maintains low cytoplasmic expression of β-catenin via
phosphorylation. Phosphorylated β-catenin can be ubiquitinated
through the F-box-containing protein, beta-transducin repeat
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containing protein, an ubiquitin E3 ligase, and then degraded
by the proteasome (Aberle et al., 1997; Kitagawa et al., 1999).
Thus, inactivation of GSK3β stabilizes β-catenin and increases its
nuclear content. As described above, bFGF-mediated activation
of Wnt signaling was apparent herein both in vitro and in vivo,
triggering the migration of fibroblasts and concomitant wound
healing. In our previous work, we found that ubiquitination-
related genes (OTUB1, Peli1, UBFD1) were altered by bFGF
stimulation observed by RNA-Seq assay, indicating that bFGF
might not only inactivate GSK3β, but also reduce proteasome-
mediated degradation of β-catenin (Xuan et al., 2016).
Also, previous studies found that β-catenin inhibits the
proliferation of murine melanoblasts and human melanoma
cells (Chien et al., 2009; Luciani et al., 2011), and may
play conflicting roles in the metastatic spread of melanoma,
repressing migration while promoting metastasis (Gallagher
et al., 2013). However, in our study, β-catenin suppression
significantly delayed the migration of NIH3T3 cells, supporting
a pro-migratory role for β-catenin. Furthermore, IWR treatment
showed a similar effect to β-catenin knock-down. Interestingly,
bFGF partially overcame the inhibitory actions of both β-
catenin repression and IWR-1. Moreover, a prior study showed
that β-catenin promotes migration, invasion, and proliferation
in colorectal, liver, lung, and breast cancers (Gallagher et al.,
2013). Combined with our observations, it is concluded
that the pro-migratory effect induced by bFGF was mainly
mediated by Wnt/β-catenin pathway, notwithstanding the effect
contributed by other signaling pathways (Xuan et al., 2014,
2016).
Notably, FGF21 expression levels were negatively influenced
by the down-regulation of β-catenin, similar to bFGF
transcription levels. FGF21 primarily activates FGFR1c, an
isoform of FGFR1, and exhibits a preference for the β-klotho
co-receptor (Yie et al., 2012; Belov and Mohammadi, 2013).
In the present study, FGF21, like bFGF, promoted normal
skin fibroblast migration, and increased the migration speed
of β-catenin-suppressing fibroblasts. β-klotho expression was
also detected in skin fibroblasts (data not shown), supporting
a role for FGF21 in the skin wound healing. In addition,
Western blot analysis showed that exogenous FGF21 treatment
activated Wnt signaling in fibroblasts to the same extent as
exogenous bFGF. These results indicate that acceleration of
fibroblast migration through the PI3K/JNK/GSK3β/β-catenin
signaling cascade acts in a feedback loop to regulate the
expression of both bFGF and FGF21. However, promoter
sequence analysis revealed that the putative β-catenin-TCF4
transcription factor complex binding motifs appeared in the
promoter of FGF21, but not in bFGF (Matsumoto et al.,
2014). For further study, it would be extremely interesting
to find the reason that β-catenin did not bind the P1-P3
regions in the promoters of bFGF. In addition, TCF4/β-catenin
complex directly regulate FGF21 transcription by ChIP
assay, implying that constitutive activation of FGF21 might
be important in cell migration process as well as bFGF.
Furthermore, FGF21 treatments still accelerated the migration
of β-catenin-suppressing fibroblast cells comparing with that
of the control groups. It may be attributed to the incomplete
suppression of endogenous β-catenin or activation of other
downstream signaling, which is able to partially rescue the cell
migration.
Based on the present results and previous works, our analyses
provide evidence for the following conclusions: (1) Wnt signaling
plays a role in FGF-mediated fibroblast migration; (2) PI3K/JNK
acts at the downstream of FGF signaling to positively regulate
GSK3β/β-catenin activity; (3) a new role for FGF21 is identified
in fibroblast migration; and (4) β-catenin also acts downstream
of FGF signaling, but in turn activates transcription of bFGF
and FGF21, two FGF family member genes. Treatment with
bFGF and FGF21 partially recovered the delayed cell migration
rates in response to reduced β-catenin expression, suggesting
that β-catenin-facilitated promotion of cell migration stems from
transcriptional activation of bFGF and FGF21, at least in part.
Nevertheless, because β-catenin also regulates the transcription
of a number of other genes, further analyses are required to
identify additional components involved in fibroblast migration
during wound healing.
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